These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 5595856)
41. Toxic epidermal necrolysis. Trans St Johns Hosp Dermatol Soc; 1967; 53(1):92-3. PubMed ID: 4865869 [No Abstract] [Full Text] [Related]
42. [Lyell's syndrome. Medicamentous etiology: probable role of chloramphenicol]. Mathé P; Aubert L; Labouche F; Kermorgant Y; Le Gall F; Wilks O J Med Bord; 1965 Aug; 142(8):1367-76. PubMed ID: 5844224 [No Abstract] [Full Text] [Related]
43. [The disease picture of acute toxic epidermolsis in children caused by drug intolerance. Report on 4 personal cases]. Sitzmann FC; Kasper W; Schuch P Z Kinderheilkd; 1967; 100(2):101-12. PubMed ID: 4298391 [No Abstract] [Full Text] [Related]
44. Toxic epidermal necrolysis secondary to timolol, dorzolamide, and latanoprost eyedrops. Flórez A; Rosón E; Conde A; González B; García-Doval I; de la Torre C; Cruces M J Am Acad Dermatol; 2005 Nov; 53(5):909-11. PubMed ID: 16243161 [No Abstract] [Full Text] [Related]
45. Moxifloxacin-associated drug hypersensitivity syndrome with toxic epidermal necrolysis and fulminant hepatic failure. Nori S; Nebesio C; Brashear R; Travers JB Arch Dermatol; 2004 Dec; 140(12):1537-8. PubMed ID: 15611441 [No Abstract] [Full Text] [Related]
46. [Iatrogenic pathology: its manifestations in stomatology]. Rodríguez De Mondelo An Esp Odontoestomatol; 1972; 31(1):21-40. PubMed ID: 4501557 [No Abstract] [Full Text] [Related]
47. Risk estimates for drugs suspected of being associated with Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control study. Lin MS; Dai YS; Pwu RF; Chen YH; Chang NC Intern Med J; 2005 Mar; 35(3):188-90. PubMed ID: 15737140 [TBL] [Abstract][Full Text] [Related]
49. [Drug allergy, with special reference to lysis of leukocytes and the fluorescent antigen technic]. Matsui T Arerugi; 1972 Apr; 21(4):303-13. PubMed ID: 4557777 [No Abstract] [Full Text] [Related]
50. [Drug side effects following internal therapy of dermatologic diseases]. Luger A Int Z Klin Pharmakol Ther Toxikol; 1972 Feb; 5(4):473-83. PubMed ID: 5046058 [No Abstract] [Full Text] [Related]
51. [Ocular manifestations during Lyell's syndrome. Apropos of 3 cases appearing after use of sulfonamides]. Saraux H; Chigot PL; Chassagne P; Devaux JP Bull Soc Ophtalmol Fr; 1965 Nov; 65(11):915-9. PubMed ID: 5866222 [No Abstract] [Full Text] [Related]
55. [Side effects of drugs used in pediatric dermatology]. Markova IV; Zver'kova FA Vestn Dermatol Venerol; 1984 Aug; (8):38-42. PubMed ID: 6385528 [No Abstract] [Full Text] [Related]
56. [Granulocytopenias due to drugs (author's transl)]. Bernasconi C Haematologica; 1979 Oct; 64 Suppl():231-8. PubMed ID: 94292 [No Abstract] [Full Text] [Related]
57. [Toxic epidermal necrolysis (Lyell's syndrome) after administration of Liv 52]. Mirov PM; Iunusova MA Klin Med (Mosk); 1982 Nov; 60(11):97-8. PubMed ID: 7154642 [No Abstract] [Full Text] [Related]
58. [Danger of drugs in childhood]. Gomirato Sandrucci M Minerva Pediatr; 1970 Jul; 22(30):1554-9. PubMed ID: 5516462 [No Abstract] [Full Text] [Related]
59. Principal toxic, allergic, and other adverse effects of antimicrobial drugs. Med Lett Drugs Ther; 1968 Sep; 10(19):73-6. PubMed ID: 5730146 [No Abstract] [Full Text] [Related]